| 000 | 01714 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515232736.0 | ||
| 264 | 0 | _c20110602 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1536-0210 | ||
| 024 | 7 |
_a10.1097/RLI.0b013e3181e960ab _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeander, Peter | |
| 245 | 0 | 0 |
_aOrally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety. _h[electronic resource] |
| 260 |
_bInvestigative radiology _cSep 2010 |
||
| 300 |
_a559-64 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAbdomen _xdiagnostic imaging |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
| 650 | 0 | 4 |
_aAscorbic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aContrast Media _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestine, Large _xdiagnostic imaging |
| 650 | 0 | 4 |
_aLiver _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aManganese _xadministration & dosage |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTrace Elements _xadministration & dosage |
| 700 | 1 | _aGolman, Klaes | |
| 700 | 1 | _aMånsson, Sven | |
| 700 | 1 | _aHöglund, Peter | |
| 773 | 0 |
_tInvestigative radiology _gvol. 45 _gno. 9 _gp. 559-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/RLI.0b013e3181e960ab _zAvailable from publisher's website |
| 999 |
_c19985641 _d19985641 |
||